Factors Associated With Mortality in Hospitalized Cardiovascular Disease Patients Infected With Covid-19 Publisher Pubmed



Alizadehsani R¹ ; Eskandarian R² ; Behjati M³ ; Zahmatkesh M² ; Roshanzamir M⁴ ; Izadi NH⁵ ; Shoeibi A^{6, 7} ; Haddadi A⁸ ; Khozeimeh F¹ ; Sani FA⁹ ; Sani ZA¹⁰ ; Roshanzamir Z¹¹ ; Khosravi A¹ ; Nahavandi S¹ Show All Authors Show Affiliations
Source: Immunity, Inflammation and Disease Published:2022

Abstract

Introduction: To reduce mortality in hospitalized patients with COVID-19 and cardiovascular disease (CVD), it is necessary to understand the relationship between patient's symptoms, risk factors, and comorbidities with their mortality rate. To the best of our knowledge, this paper is the first which take into account the determinants like risk factors, symptoms, and comorbidities leading to mortality in CVD patients who are hospitalized with COVID-19. Methods: This study was conducted on 660 hospitalized patients with CVD and COVID-19 recruited between January 2020 and January 2021 in Iran. All patients were diagnosed with the previous history of CVD like angina, myocardial infarction, heart failure, cardiomyopathy, abnormal heart rhythms, and congenital heart disease before they were hospitalized for COVID-19. We collected data on patient's signs and symptoms, clinical and paraclinical examinations, and any underlying comorbidities. t test was used to determine the significant difference between the two deceased and alive groups. In addition, the relation between pairs of symptoms and pairs of comorbidities has been determined via correlation computation. Results: Our findings suggest that signs and symptoms such as fever, cough, myalgia, chest pain, chills, abdominal pain, nausea, vomiting, diarrhea, and anorexia had no impact on patients' mortality. There was a significant correlation between COVID-19 cardiovascular patients' mortality rate and symptoms such as headache, loss of consciousness (LOC), oxygen saturation less than 93%, and need for mechanical ventilation. Conclusions: Our results might help physicians identify early symptoms, comorbidities, and risk factors related to mortality in CVD patients hospitalized for COVID-19. © 2021 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd.